Home-based rehabilitation program for COPD patients
Home-based Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease
NA · Polytechnic Institute of Porto · NCT04722224
This study is testing a home-based rehab program for people with COPD to see if it helps them breathe better and improve their overall health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 40 Years to 90 Years |
| Sex | All |
| Sponsor | Polytechnic Institute of Porto (other) |
| Locations | 1 site (Porto) |
| Trial ID | NCT04722224 on ClinicalTrials.gov |
What this trial studies
This project evaluates the effectiveness of a home-based pulmonary rehabilitation program called reabilitAR for patients with chronic obstructive pulmonary disease (COPD). The program combines exercise training and self-management education delivered through home visits and phone calls over a 12-week period. Researchers will collect various health metrics, including lung function and exercise capacity, before and after the intervention to assess its impact. The study aims to improve access to pulmonary rehabilitation services, which are often underutilized due to accessibility issues.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with COPD according to the GOLD criteria.
Not a fit: Patients with significant cardiovascular, neurological, or musculoskeletal conditions, or those showing signs of cognitive impairment may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly enhance the quality of life and functional capacity for patients with COPD.
How similar studies have performed: Other studies have shown positive outcomes with home-based pulmonary rehabilitation approaches, indicating potential for success in this novel program.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of COPD based on the GOLD criteria - postbronchodilator forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio \<70%; * Electrocardiogram (ECG) record at rest; * Written informed consent form; Exclusion Criteria: * Presence of any clinical condition that does not allow the participants to a home-based PR program, such as, significant cardiovascular (e.g. symptomatic ischaemic cardiac disease), neurological (e.g. neuromuscular dystrophy disease), or presence of musculoskeletal disease; * Signs of cognitive impairment (e.g. dementia).
Where this trial is running
Porto
- Rui Vilarinho — Porto, Portugal (RECRUITING)
Study contacts
- Principal investigator: Rui A Vilarinho, Master — School of Health, Polytechnic Institute of Porto
- Study coordinator: Rui A Vilarinho, Master
- Email: ruivilarinho1@gmail.com
- Phone: 222 061 000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: COPD, home-based pulmonary rehabilitation, exercise training, self-management